Apeiron Therapeutics
PrivateLast Round
Series A
Mar 29, 2022
Total Funding Raised
$44.5M
Company Overview
Apeiron Therapeutics is a biotechnology company that develops biomarker-driven cancer therapeutics using a structure-based, AI-driven drug design platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Apeiron Therapeutics Comparables
Compare Apeiron Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Recursion Pharmaceuticals | 81% | |
| Tango Therapeutics | 80% | |
| Bristol Myers Squibb | 78% |
Apeiron Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 29, 2022 | ||||
| Seed | Jun 11, 2019 |
Apeiron Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Viva BioInnovator | Series A |
| GT Healthcare Capital Partners | Seed |
| Panacea Venture Healthcare | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Monthly visitors grew 80% MoM, reaching 1.2K.
- May 1, 2025
Monthly visitors grew 298% MoM, from 377 to 1.5K.
Apeiron Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Apeiron Therapeutics's valuation, stock price, and market status.
Is Apeiron Therapeutics a public or private company?
Apeiron Therapeutics is a private company.
What is the current stock price of Apeiron Therapeutics?
Apeiron Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Apeiron Therapeutics worth (valuation)?
Valuation information for Apeiron Therapeutics is not publicly available.
Can I buy Apeiron Therapeutics stock?
Apeiron Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Apeiron Therapeutics's last funding round?
Apeiron Therapeutics's most recent funding round was Series A on March 29, 2022.
Who are the main investors in Apeiron Therapeutics?
Investor information for Apeiron Therapeutics is not publicly disclosed.
Will Apeiron Therapeutics IPO soon?
No public IPO plans have been announced for Apeiron Therapeutics.
How can I track Apeiron Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Apeiron Therapeutics's secondary market activity and sign up for updates.